FDA Authorizes NGS Test Marketing For Detecting HIV-1 Drug Resistance
Posted by
www.biotecnika.org
FDA Authorizes HIV-1 drug The FDA has approved the for marketing the
Sentosa SQ HIV Genotyping Assay, which is the first HIV drug-resistant
assay used in next-generation sequencing technology. The capability to
logically choose therapies for patients ready to start or already
taking antiviral treatment offers an additional device in our ongoing
fight versus HIV," […]
The post FDA Authorizes NGS Test Marketing For Detecting HIV-1 Drug
Resistance appeared first on BioTecNika .
https://www.biotecnika.org/2019/11/fda-authorized-hiv-1-drug-resistant-mutation-using-next-ngs-test/
Uncategorized
Subscribe to:
Post Comments (Atom)
Post a Comment